Skip to main content
Log in

Drug Interactions with Levothyroxine Therapy in Patients with Hypothyroidism: Observational Study in General Practice

  • Original Research Article
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

Abstract

Background and Objectives

Several drugs may interact with levothyroxine and reduce its bioavailability. The aim of this study was to analyse the Italian general practice patients with hypothyroidism from 2002–2011, in terms of variation of thyroid-stimulating hormone (TSH) levels, number of levothyroxine prescriptions and dose of levothyroxine before and during potential drug–drug interactions (DDIs).

Methods

Data were extracted from the Italian general practice Health Search CSD Longitudinal Patient Database (HSD). Analysis was limited to individuals aged 18 years and older with at least one levothyroxine prescription from 2002 to 2011 and at least one year of clinical history recorded in HSD. A quasi-experimental pre-post analysis was carried out using a self-controlled study design, on an intention-to-treat basis.

Results

Overall, 5,426 levothyroxine users (7.5 % of population in HSD) were included in the study. The incidence rate ratio comparing the TSH trend before and during the period of exposure to potential DDI showed a significant increase of TSH levels during initial exposure to potential DDI, which decreased over time. The number of prescriptions and dose of levothyroxine decreased before the potential DDI and increased symmetrically during the period of exposure to potential DDI.

Conclusions

The co-prescription of levothyroxine and potentially interacting drugs results in an increased use of levothyroxine. Clinicians should carefully consider adjusting levothyroxine therapy in presence of concomitant drugs, such as proton-pump inhibitors, which may reduce levothyroxine bioavailability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39–51.

    Article  PubMed  Google Scholar 

  2. Latina A, Gullo D, Trimarchi F, Benvenga S. Hashimoto’s thyroiditis: similar and dissimilar characteristics in neighboring areas. Possible implications for the epidemiology of thyroid cancer. PLoS One. 2013;8(3):e55450.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Osservatorio sull’uso dei farmaci in Italia. Rapporto OsMed. 2011. http://www.agenziafarmaco.gov.it/sites/default/files/1_-_rapporto_osmed_2011.pdf. Accessed 23 Dec 2014

  4. Vaidya B, Pearce SH. Management of hypothyroidism in adults. Br Med J. 2008;337(a):801.

  5. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA. American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988–1028.

    Article  PubMed  Google Scholar 

  6. Barbesino G. Drugs affecting thyroid function. Thyroid. 2010;20(7):763–70.

    Article  PubMed  Google Scholar 

  7. Larson J, Anderson EH, Koslawy M. Thyroid disease: a review for primary care. J Am Assoc Nurse Pract. 2000;12(6):226–32.

    Article  CAS  Google Scholar 

  8. Zamfirescu I, Carlson HE. Absorption of levothyroxine when co-administered with various calcium formulations. Thyroid. 2011;21(5):483–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Sachmechi I, Reich DM, Aninyei M, Wibowo F, Gupta G, Kim PJ. Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism. Endocr Pract. 2007;13(4):345–9.

    Article  PubMed  Google Scholar 

  10. Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000;283(21):2822–5.

    Article  CAS  PubMed  Google Scholar 

  11. Singh N, Weisler SL, Hershman JM. The acute effect of calcium carbonate on the intestinal absorption of levothyroxine. Thyroid. 2001;11(10):967–71.

    Article  CAS  PubMed  Google Scholar 

  12. Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB. Effect of phosphate binders upon TSH and l-thyroxine dose in patients on thyroid replacement. Int Urol Nephrol. 2007;39(2):599–602.

  13. A Irving S, Vadiveloo T, Leese GP. Drugs that interact with levothyroxine: an observational study from the Thyroid Epidemiology, Audit and Research Study (TEARS). Clin Endocrinol (Oxf). 2015;82(1):136–41.

  14. Sultana J, Italiano D, Spina E, Cricelli C, Lapi F, Pecchioli S, et al. Changes in the prescribing pattern of antidepressant drugs in elderly patients: an Italian, nationwide, population-based study. Eur J Clin Pharmacol. 2014;70(4):469–78.

    Article  PubMed  Google Scholar 

  15. Filippi A, Vanuzzo D, Bignamini AA, Sessa E, Brignoli O, Mazzaglia G. Computerized general practice databases provide quick and cost-effective information on the prevalence of angina pectoris. Ital Heart J. 2005;6(1):49–51.

  16. Cricelli C, Mazzaglia G, Samani F, Marchi M, Sabatini A, Nardi R et al. Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med. 2003;25(3):254–7.

  17. Trifirò G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, et al. Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study. Ann Rheum Dis. 2012;72(5):694–700.

    Article  PubMed  Google Scholar 

  18. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120(16):1598–605.

    Article  CAS  PubMed  Google Scholar 

  19. Sathi P, Kalyan S, Hitchcock CL, Pudek M, Prior JC. Progesterone therapy increases free thyroxine levels–data from a randomized placebo-controlled 12-week hot flush trial. Clin Endocrinol (Oxf). 2013;79(2):282–7.

    Article  CAS  Google Scholar 

  20. Haugen BR. Drugs that suppress tsh or cause central hypothyroidism. Best Pract Res Clin Endocrinol Metab. 2009;23(6):793–800.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59(10):1087–91.

    Article  PubMed  Google Scholar 

  22. Centanni M, Gargano L, Canettieri G, Viceconti N, Franchi A, Delle Fave G, et al. Thyroxine in goiter, Helicobacter pylori infection and chronic gastritis. N Engl J Med. 2006;354(17):1787–95.

    Article  CAS  PubMed  Google Scholar 

  23. Pincus D, Gomes T, Hellings C, Zheng H, Paterson JM, Mamdani MM, et al. A population-based assessment of the drug interaction between levothyroxine and warfarin. Clin Pharmacol Ther. 2012;92(6):766–70.

  24. Taylor PN, Iqbal A, Minassian C, Sayers A, Draman MS, Greenwood R, et al. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. JAMA Intern Med. 2014;174(1):32–9.

    Article  CAS  PubMed  Google Scholar 

  25. Liwanpo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 2009;23(6):781–92.

  26. Siraj ES, Gupta MK, Reddy SS. Raloxifene causing malabsorption of levothyroxine. Arch Intern Med. 2003;163(11):1367–70.

    Article  PubMed  Google Scholar 

  27. John-Kalarickal J, Pearlman G, Carlson HE. New medications which decrease levothyroxine absorption. Thyroid. 2007;17(8):763–5.

    Article  CAS  PubMed  Google Scholar 

  28. Weitzman SP, Ginsburg KC, Carlson HE. Colesevelam hydrochloride and lanthanum carbonate interfere with the absorption of levothyroxine. Thyroid. 2009;19(1):77–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Vigersky RA, Filmore-Nassar A, Glass AR. Thyrotropin suppression by metformin. J Clin Endocrinol Metab. 2006;91(1):225–7.

  30. Wood MD, Delate T, Clark M, Clark N, Horn JR, Witt DM. An evaluation of the potential drug interaction between warfarin and levothyroxine. J Thromb Haemost. 2014;12(8):1313–9. doi:10.1111/jth.12626.

    Article  CAS  PubMed  Google Scholar 

  31. Ananthakrishnan S, Braverman LE, Levin RM, et al. The effect of famotidine, esomeprazole and ezetimibe on levothyroxine absorption. Thyroid. 2008;18(5):493–8.

    Article  CAS  PubMed  Google Scholar 

  32. Dietrich JW, Gieselbrecht K, Holl RW, et al. Absorption kinetics of levothyroxine is notaltered by proton-pump inhibitor therapy. Horm Metab Res. 2006;38(1):57–9.

    Article  CAS  PubMed  Google Scholar 

  33. Ingrasciotta Y, Sultana J, Giorgianni F, Caputi AP, Arcoraci V, Tari DU, et al. The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy. PLoS One. 2014;9(2):e89072.

    Article  PubMed Central  PubMed  Google Scholar 

  34. Vita R, Benvenga S. Tablet levothyroxine (L-T4) malabsorption induced by proton pump inhibitor; a problem that was solved by switching to L-T4 in soft gel capsule. Endoc Pract. 2014;20(3):e38–41.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gianluca Trifirò.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 27 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trifirò, G., Parrino, F., Sultana, J. et al. Drug Interactions with Levothyroxine Therapy in Patients with Hypothyroidism: Observational Study in General Practice. Clin Drug Investig 35, 187–195 (2015). https://doi.org/10.1007/s40261-015-0271-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40261-015-0271-0

Keywords

Navigation